Internal Medicine, Cardiovascular Disease · Madisonville, KY
NPI
1023065745
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
550 Hospital Dr, Suite B
Madisonville, KY, 42431
Phone (270) 821-5454
Groups this clinician bills Medicare through
Medicare paid, 2024
$225K
3,537 services
Medicare patients, 2024
1,035
Average age 75
Drug cost, 2024
$1.2M
12,625 prescriptions
Company payments, 2025
$489
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deepak Kapadia was code 99214 (office e&m - established), 762 times for 591 patients. In total Deepak Kapadia billed 3,537 services in 38 codes, and Medicare paid $225K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 762 | 591 | $85.80 | $65K |
| 93000 Electrocardiogram | Office | 671 | 478 | $9.37 | $6,288 |
| 99232 Hospital E&M - Subsequent | Facility | 394 | 131 | $58.48 | $23K |
| 93306 Echocardiography (TTE/TEE) | Office | 362 | 362 | $125.51 | $45K |
| 99213 Office E&M - Established | Office | 290 | 252 | $54.80 | $16K |
| 93010 Electrocardiogram | Facility | 215 | 157 | $6.38 | $1,372 |
| 99222 Hospital E&M - Initial | Facility | 201 | 177 | $97.05 | $20K |
| 93306 Echocardiography (TTE/TEE) | Facility | 171 | 159 | $50.82 | $8,690 |
| 93294 External Electrocardiographic Monitoring | Office | 99 | 32 | $20.70 | $2,050 |
| 93280 External Electrocardiographic Monitoring | Office | 66 | 45 | $51.18 | $3,378 |
| 93458 Percutaneous Transcatheterization | Facility | 43 | 42 | $183.32 | $7,883 |
| 99204 Office E&M - New | Office | 42 | 42 | $99.30 | $4,171 |
| 93288 External Electrocardiographic Monitoring | Office | 26 | 23 | $35.23 | $916 |
| 93283 External Electrocardiographic Monitoring | Office | 21 | 15 | $70.23 | $1,475 |
| 92928 Percutaneous Coronary Artery Angioplasty and Stenting | Facility | 19 | 18 | $418.55 | $7,952 |
By year: 2022 $251K for 5,044 services; 2023 $234K for 4,617 services; 2024 $225K for 3,537 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deepak Kapadia prescribed most often to Medicare patients was Metoprolol Tartrate, with 989 prescriptions and refills. In total Deepak Kapadia wrote 12,625 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Tartrate Generic | 989 | 2,377 | 276 | $3,805 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 917 | 2,270 | 256 | $8,309 |
| Clopidogrel Clopidogrel Bisulfate | 881 | 2,267 | 247 | $7,870 |
| Furosemide Generic | 685 | 1,618 | 196 | $2,303 |
| Losartan Potassium Generic | 672 | 1,772 | 193 | $5,841 |
| Carvedilol Generic | 623 | 1,484 | 168 | $3,340 |
| Eliquis Apixaban | 553 | 987 | 117 | $554K |
| Ranolazine Er Ranolazine | 541 | 1,086 | 131 | $42K |
| Atorvastatin Calcium Generic | 461 | 1,204 | 132 | $3,779 |
| Metoprolol Succinate Generic | 442 | 1,038 | 122 | $6,132 |
| Amiodarone Hcl Generic | 406 | 922 | 119 | $20K |
| Lisinopril Generic | 346 | 915 | 103 | $1,948 |
| Spironolactone Generic | 342 | 782 | 99 | $1,912 |
| Amlodipine Besylate Generic | 294 | 643 | 73 | $866 |
| Pravastatin Sodium Generic | 221 | 566 | 59 | $2,316 |
Brand drugs: - claims; generic drugs: 11,286 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deepak Kapadia $489 ($489 in general payments such as food, travel and fees) from 10 companies. The largest payer was ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) with $111.
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $111 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $75.54 |
| Merck Sharp & Dohme LLC MRK | 4 | $69.62 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $57.19 |
| GlaxoSmithKline, LLC. GSK | 2 | $44.27 |
| Amgen Inc. AMGN | 2 | $40.85 |
| Edwards Lifesciences Corporation EW | 1 | $28.69 |
| Scpharmaceuticals Inc. SCPH | 1 | $22.65 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $20.48 |
| Esperion Therapeutics, Inc. ESPR | 1 | $17.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.